HEM Pharma
Latest round
- Series A
Last raised
- Aug 2020
Total raised
- $12M
Investors
- 7
About HEM Pharma
Founded in 2017 and based in Pohang, South Korea, HEM Pharma operates as a pharmaceutical development and healthcare company that uses microbiomes to analyze and improve human health. The firm’s customers include Amway, Phyto Genomics, Enfominance, Samyang, GDK Cosmetics, etc. The company was listed in the KOSDAQ market in November 2024.23 million shares in HEM Pharma at KRW 43,912 for KRW 54 billion, in a PIPE transaction.
Who invested in HEM Pharma
7 investors across 1 round
See all investors in HEM Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 14, 2020
Amount
$12M
Investors
Questions about HEM Pharma
Who invested in HEM Pharma?
HEM Pharma has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HEM Pharma raised?
HEM Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HEM Pharma last raise money?
HEM Pharma's most recent round on record is a Series A, in Aug 2020.
What does HEM Pharma do?
Founded in 2017 and based in Pohang, South Korea, HEM Pharma operates as a pharmaceutical development and healthcare company that uses microbiomes to analyze and improve human health.
Where is HEM Pharma headquartered?
HEM Pharma is headquartered in Pohang, South Korea.
Which VCs invest in companies like HEM Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at HEM Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like HEM Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.